NCT02696850View on ClinicalTrials.gov

The Impact Of The Addition Of Budesonide To Low-Pressure, High-Volume Saline Sinus Irrigation For Chronic Rhinosinusitis

PHASE4CompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

January 1, 2016

Primary Completion Date

April 13, 2017

Study Completion Date

April 13, 2017

Conditions
RhinosinusitisChronic Eosinophilic RhinosinusitisAllergic Rhinosinusitis
Interventions
DRUG

Budesonide

Participants will undergo 4-week treatment course that includes budesonide powder added to saline rinse.

DRUG

Saline alone

Participants will undergo 4-week treatment course that includes lactose (placebo) powder added to saline rinse.

Trial Locations (1)

63110

Washington University School of Medicine, St Louis

All Listed Sponsors
lead

Washington University School of Medicine

OTHER

NCT02696850 - The Impact Of The Addition Of Budesonide To Low-Pressure, High-Volume Saline Sinus Irrigation For Chronic Rhinosinusitis | Biotech Hunter | Biotech Hunter